Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilesh Kumar

Showing results (71-80 of 335) with videos related to

Pageof 34
Sort By:
Eye (London, England)|September 21, 2019
Brolucizimab-leading an era of structural revolution for long-term VEGF suppressionAshish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Plos One|November 7, 2024
Understanding the success factors of MOOCs' retention intention: A Necessary Condition AnalysisZhang Huacui, Md Nahin Hossain, Kong Zhen, et al.
Microrna (Shariqah, United Arab Emirates)|December 21, 2018
Induction of S-phase Cell Cycle Arrest and Apoptosis in HeLa Cells by Small RNAs Fraction of <i>Solanum tuberosum</i> LSunny Yadav, Devashree Jahagirdar, Mamta Shekhawat, et al.
Ophthalmology|October 23, 2019
Re: Campochiaro et al.: The Port Delivery System with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 Ladder clinical trial (Ophthalmology. 2019;126:1141-1154)Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Cardiovascular & Hematological Disorders Drug Targets|September 26, 2024
Dengue Fever Related Reactive Thrombocytosis in Young Male: A Case Report and Review LiteratureJitendra Singh, Anju Dinkar, Nilesh Kumar, et al.
Indian Journal of Dental Research : Official Publication of Indian Society for Dental Research|April 8, 2016
Video laryngoscope: A boon for airway management in severe facial traumaShailendra Kumar, Sweta Singh, Nilesh Kumar, et al.
Cancer Biology & Medicine|September 9, 2017
Natural and artificial small RNAs: a promising avenue of nucleic acid therapeutics for cancerSunny Yadav, Mamta Shekhawat, Devashree Jahagirdar, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 29, 2017
Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinomaAjay Kumar, Pritish Nilednu, Azad Kumar, et al.
Journal of Cancer Prevention|April 7, 2017
Non-homologous End Joining Inhibitor SCR-7 to Exacerbate Low-dose Doxorubicin Cytotoxicity in HeLa CellsAjay Kumar, Devyani Bhatkar, Devashree Jahagirdar, et al.
Future Oncology (London, England)|April 8, 2020
Molecular avenues in targeted doxorubicin cancer therapySayantani Roychoudhury, Ajay Kumar, Devyani Bhatkar, et al.
Pageof 34

Showing results (71-80 of 335) with videos related to

Sort By:
Pageof 34
Eye (London, England)|September 21, 2019
Brolucizimab-leading an era of structural revolution for long-term VEGF suppressionAshish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Plos One|November 7, 2024
Understanding the success factors of MOOCs' retention intention: A Necessary Condition AnalysisZhang Huacui, Md Nahin Hossain, Kong Zhen, et al.
Microrna (Shariqah, United Arab Emirates)|December 21, 2018
Induction of S-phase Cell Cycle Arrest and Apoptosis in HeLa Cells by Small RNAs Fraction of <i>Solanum tuberosum</i> LSunny Yadav, Devashree Jahagirdar, Mamta Shekhawat, et al.
Ophthalmology|October 23, 2019
Re: Campochiaro et al.: The Port Delivery System with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 Ladder clinical trial (Ophthalmology. 2019;126:1141-1154)Ashish Sharma, Nilesh Kumar, Baruch D Kuppermann, et al.
Cardiovascular & Hematological Disorders Drug Targets|September 26, 2024
Dengue Fever Related Reactive Thrombocytosis in Young Male: A Case Report and Review LiteratureJitendra Singh, Anju Dinkar, Nilesh Kumar, et al.
Indian Journal of Dental Research : Official Publication of Indian Society for Dental Research|April 8, 2016
Video laryngoscope: A boon for airway management in severe facial traumaShailendra Kumar, Sweta Singh, Nilesh Kumar, et al.
Cancer Biology & Medicine|September 9, 2017
Natural and artificial small RNAs: a promising avenue of nucleic acid therapeutics for cancerSunny Yadav, Mamta Shekhawat, Devashree Jahagirdar, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 29, 2017
Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinomaAjay Kumar, Pritish Nilednu, Azad Kumar, et al.
Journal of Cancer Prevention|April 7, 2017
Non-homologous End Joining Inhibitor SCR-7 to Exacerbate Low-dose Doxorubicin Cytotoxicity in HeLa CellsAjay Kumar, Devyani Bhatkar, Devashree Jahagirdar, et al.
Future Oncology (London, England)|April 8, 2020
Molecular avenues in targeted doxorubicin cancer therapySayantani Roychoudhury, Ajay Kumar, Devyani Bhatkar, et al.
Pageof 34